DVL1 anticorps
Aperçu rapide pour DVL1 anticorps (ABIN630212)
Antigène
Voir toutes DVL1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Purification
- Purified
-
Immunogène
- DVL1 antibody was raised using a synthetic peptide corresponding to a region with amino acids AAGAGGSGSESDHTAPSGVGSSWRERPAGQLSRGSSPRSQASATAPGLPP
-
-
-
-
Indications d'application
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
DVL1 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this DVL1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of DVL1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- DVL1 (Dishevelled Segment Polarity Protein 1 (DVL1))
-
Autre désignation
- DVL1
-
Sujet
- DVL1 is a cytoplasmic phosphoprotein that regulates cell proliferation, acting as a transducer molecule for developmental processes, including segmentation and neuroblast specification. DVL1 gene is a candidate for neuroblastomatous transformation. The Schwartz-Jampel syndrome and Charcot-Marie-Tooth disease type 2A have been mapped to the same region as DVL1 gene. The phenotypes of these diseases may be consistent with defects which might be expected from aberrant expression of a DVL gene during development.
-
Poids moléculaire
- 73 kDa (MW of target protein)
-
Pathways
- Signalisation WNT, Synaptic Membrane, Skeletal Muscle Fiber Development
Antigène
-